Pacific Biosciences Of California Total Current Assets 2010-2024 | PACB

Pacific Biosciences Of California total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Pacific Biosciences Of California Annual Total Current Assets
(Millions of US $)
2023 $742
2022 $852
2021 $1,101
2020 $356
2019 $81
2018 $132
2017 $102
2016 $109
2015 $111
2014 $118
2013 $126
2012 $115
2011 $200
2010 $293
2009 $94
Pacific Biosciences Of California Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $628
2024-03-31 $677
2023-12-31 $742
2023-09-30 $882
2023-06-30 $936
2023-03-31 $981
2022-12-31 $852
2022-09-30 $914
2022-06-30 $970
2022-03-31 $1,029
2021-12-31 $1,101
2021-09-30 $1,130
2021-06-30 $1,189
2021-03-31 $1,196
2020-12-31 $356
2020-09-30 $240
2020-06-30 $151
2020-03-31 $170
2019-12-31 $81
2019-09-30 $77
2019-06-30 $99
2019-03-31 $113
2018-12-31 $132
2018-09-30 $144
2018-06-30 $96
2018-03-31 $116
2017-12-31 $102
2017-09-30 $114
2017-06-30 $133
2017-03-31 $88
2016-12-31 $109
2016-09-30 $122
2016-06-30 $138
2016-03-31 $119
2015-12-31 $111
2015-09-30 $86
2015-06-30 $90
2015-03-31 $100
2014-12-31 $118
2014-09-30 $114
2014-06-30 $120
2014-03-31 $132
2013-12-31 $126
2013-09-30 $142
2013-06-30 $122
2013-03-31 $126
2012-12-31 $115
2012-09-30 $132
2012-06-30 $153
2012-03-31 $177
2011-12-31 $200
2011-09-30 $220
2011-06-30 $245
2011-03-31 $264
2010-12-31 $293
2010-09-30 $117
2010-06-30
2010-03-31
2009-12-31
2009-09-30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.601B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $206.837B 25.23
Intuitive Surgical (ISRG) United States $191.293B 100.01
Alcon (ALC) Switzerland $42.858B 28.68
Edwards Lifesciences (EW) United States $38.815B 24.65
IQVIA Holdings (IQV) United States $38.763B 21.36
IDEXX Laboratories (IDXX) United States $34.892B 41.09
DexCom (DXCM) United States $29.037B 43.73
Waters (WAT) United States $22.907B 33.87
STERIS (STE) Ireland $21.985B 25.31
SONOVA HOLDING (SONVY) Switzerland $21.643B 0.00
Hologic (HOLX) United States $18.526B 19.55
Sysmex ADR (SSMXY) Japan $12.594B 39.49
Fresenius Medical Care AG KGaA (FMS) Germany $12.447B 12.78
Globus Medical (GMED) United States $11.296B 28.77
Teleflex (TFX) United States $9.083B 14.49
Penumbra (PEN) United States $9.066B 88.81
Masimo (MASI) United States $8.612B 41.67
Glaukos (GKOS) United States $7.919B 0.00
PROCEPT BioRobotics (PRCT) United States $4.986B 0.00
Integer Holdings (ITGR) United States $4.592B 26.02
TransMedics (TMDX) United States $3.068B 97.25
Inari Medical (NARI) United States $3.003B 0.00
Veracyte (VCYT) United States $2.964B 88.93
LivaNova (LIVN) United Kingdom $2.878B 16.61
Nihon Kohden (NHNKY) Japan $2.557B 19.42
Elekta AB (EKTAY) Sweden $2.252B 18.35
Tandem Diabetes Care (TNDM) United States $2.043B 0.00
Integra LifeSciences Holdings (IART) United States $1.914B 10.00
RxSight (RXST) United States $1.832B 0.00
Alphatec Holdings (ATEC) United States $1.316B 0.00
Artivion (AORT) United States $1.162B 77.03
OPKO Health (OPK) United States $1.099B 0.00
Pulse Biosciences (PLSE) United States $1.091B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.915B 15.55
ORTHOFIX MEDICAL INC (OFIX) United States $0.735B 0.00
IRadimed (IRMD) United States $0.722B 39.01
SiBone (SIBN) United States $0.652B 0.00
Paragon 28 (FNA) United States $0.627B 0.00
Mesa Laboratories (MLAB) United States $0.610B 14.39
AxoGen (AXGN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.582B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.383B 0.00
Semler Scientific (SMLR) United States $0.383B 25.71
Tactile Systems Technology (TCMD) United States $0.378B 20.45
Delcath Systems (DCTH) United States $0.310B 0.00
ClearPoint Neuro (CLPT) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.249B 0.00
Sight Sciences (SGHT) United States $0.215B 0.00
NeuroPace (NPCE) United States $0.208B 0.00
Accuray (ARAY) United States $0.192B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
Sensus Healthcare (SRTS) United States $0.117B 17.44
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
908 Devices (MASS) United States $0.101B 0.00
EDAP TMS S.A (EDAP) France $0.098B 0.00
LENSAR (LNSR) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
WORK Medical Technology Group (WOK) China $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.061B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Lucid Diagnostics (LUCD) United States $0.054B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Accelerate Diagnostics (AXDX) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
Neuronetics (STIM) United States $0.021B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00